Completed NA INTERVENTIONAL 1-arm NCT06639698

Treatment of Women With PCOS of Phenotype D (PT-PHD)

Treatment of Menstrual Cycle Alterations in Women With PCOS of Phenotype D Using Dietary Supplementation That Combines Diosgenin, Vitamin D and Alpha-lactalbumin

Sponsor: Lo.Li.Pharma s.r.l

Conditions PCOS (Polycystic Ovary Syndrome)

Interventions Diosgenin

Updated 2 times since 2024 Last updated: Jul 24, 2025 Started: Oct 14, 2024 Primary completion: May 30, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06639698, this NA trial focuses on PCOS (Polycystic Ovary Syndrome) and remains completed. Sponsored by Lo.Li.Pharma s.r.l, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Nov 2024 — Aug 2025 [monthly]

Recruiting NA

First recorded

Oct 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lo.Li.Pharma s.r.l

Data source: Lo.Li.Pharma s.r.l

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy